Raquel Buj

738 total citations
16 papers, 351 citations indexed

About

Raquel Buj is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Raquel Buj has authored 16 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Raquel Buj's work include Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (5 papers) and RNA modifications and cancer (3 papers). Raquel Buj is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (5 papers) and RNA modifications and cancer (3 papers). Raquel Buj collaborates with scholars based in United States, Spain and Palestinian Territory. Raquel Buj's co-authors include Katherine M. Aird, Kelly E. Leon, Chi‐Wei Chen, Dı́dac Mauricio, Jordi L. Reverter, Manel Puig‐Domingo, Yuka Imamura Kawasawa, Mireia Jordà, Miguel A. Peinado and Mercedes Robledo and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Raquel Buj

16 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Buj United States 11 236 89 73 62 52 16 351
Gregory Miles United States 5 199 0.8× 117 1.3× 88 1.2× 25 0.4× 37 0.7× 5 345
Ira P. Maine United States 8 276 1.2× 76 0.9× 41 0.6× 51 0.8× 34 0.7× 10 382
Joan Duran Spain 8 232 1.0× 188 2.1× 46 0.6× 42 0.7× 22 0.4× 11 360
PengXin Zhang China 9 261 1.1× 55 0.6× 97 1.3× 11 0.2× 40 0.8× 31 386
Bentley Varghese United States 8 218 0.9× 83 0.9× 156 2.1× 18 0.3× 61 1.2× 9 424
TaeJeong Oh South Korea 10 210 0.9× 97 1.1× 120 1.6× 23 0.4× 93 1.8× 14 385
Martin Kirschner Germany 13 196 0.8× 29 0.3× 87 1.2× 88 1.4× 12 0.2× 33 389
H Matsuzaki Japan 12 191 0.8× 41 0.5× 105 1.4× 27 0.4× 58 1.1× 28 390
Agnieszka Piętas Germany 6 383 1.6× 135 1.5× 69 0.9× 17 0.3× 16 0.3× 6 454
Louie Semaan United States 8 169 0.7× 88 1.0× 106 1.5× 18 0.3× 25 0.5× 10 347

Countries citing papers authored by Raquel Buj

Since Specialization
Citations

This map shows the geographic impact of Raquel Buj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Buj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Buj more than expected).

Fields of papers citing papers by Raquel Buj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Buj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Buj. The network helps show where Raquel Buj may publish in the future.

Co-authorship network of co-authors of Raquel Buj

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Buj. A scholar is included among the top collaborators of Raquel Buj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Buj. Raquel Buj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Buj, Raquel, Jiefei Wang, Aidan R. Cole, et al.. (2024). De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer Research Communications. 4(5). 1174–1188. 4 indexed citations
2.
Huang, Zhentai, Chi‐Wei Chen, Raquel Buj, et al.. (2022). ATM inhibition drives metabolic adaptation via induction of macropinocytosis. The Journal of Cell Biology. 222(1). 10 indexed citations
3.
Leon, Kelly E., Raquel Buj, Chi‐Wei Chen, et al.. (2021). DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. The Journal of Cell Biology. 220(8). 41 indexed citations
4.
Leon, Kelly E., et al.. (2021). Loss of p16: A Bouncer of the Immunological Surveillance?. Life. 11(4). 309–309. 13 indexed citations
5.
Buj, Raquel, et al.. (2021). Suppression of p16 alleviates the senescence-associated secretory phenotype. Aging. 13(3). 3290–3312. 47 indexed citations
6.
7.
Chen, Chi‐Wei, et al.. (2020). ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells. Heliyon. 6(9). e05097–e05097. 9 indexed citations
8.
Buj, Raquel, Kelly E. Leon, Jordan M. Newell, et al.. (2019). Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer. Molecular Cancer Research. 17(8). 1710–1720. 23 indexed citations
9.
Buj, Raquel & Katherine M. Aird. (2019). p16: cycling off the beaten path. Molecular & Cellular Oncology. 6(6). e1677140–e1677140. 16 indexed citations
10.
Buj, Raquel & Katherine M. Aird. (2018). Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease. Frontiers in Endocrinology. 9. 177–177. 53 indexed citations
11.
Buj, Raquel, Peining Xu, Mary T. Doan, et al.. (2018). Simultaneous isotope dilution quantification and metabolic tracing of deoxyribonucleotides by liquid chromatography high resolution mass spectrometry. Analytical Biochemistry. 568. 65–72. 9 indexed citations
12.
Buj, Raquel, Izaskun Mallona, Anna Díez-Villanueva, et al.. (2018). Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications. Thyroid. 28(5). 601–612. 15 indexed citations
13.
Hesselink, Esther N. Klein, Carles Zafón, Núria Villalmanzo, et al.. (2017). Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 103(2). 397–406. 25 indexed citations
14.
Buj, Raquel, Izaskun Mallona, Anna Díez-Villanueva, et al.. (2016). Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples. Oncotarget. 7(9). 10536–10546. 15 indexed citations
15.
Mančíková, Veronika, Raquel Buj, Esmeralda Castelblanco, et al.. (2014). DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival. International Journal of Cancer. 135(3). 598–610. 61 indexed citations
16.
Buj, Raquel, et al.. (2013). A plasmid toolkit for cloning chimeric cDNAs encoding customized fusion proteins into any Gateway destination expression vector. BMC Molecular Biology. 14(1). 18–18. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory Miles Breakdown of academic impact, for papers by Ira P. Maine Breakdown of academic impact, for papers by Joan Duran Breakdown of academic impact, for papers by PengXin Zhang Breakdown of academic impact, for papers by Bentley Varghese Breakdown of academic impact, for papers by TaeJeong Oh Breakdown of academic impact, for papers by Martin Kirschner Breakdown of academic impact, for papers by H Matsuzaki Breakdown of academic impact, for papers by Agnieszka Piętas Breakdown of academic impact, for papers by Louie Semaan
Rankless by CCL
2026